These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16305402)

  • 1. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.
    Diwan M; Elamanchili P; Cao M; Samuel J
    Curr Drug Deliv; 2004 Oct; 1(4):405-12. PubMed ID: 16305402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
    Diwan M; Tafaghodi M; Samuel J
    J Control Release; 2002 Dec; 85(1-3):247-62. PubMed ID: 12480329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
    Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.
    Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J
    J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors.
    Liu C; Chu X; Yan M; Qi J; Liu H; Gao F; Gao R; Ma G; Ma Y
    Int J Pharm; 2018 Dec; 553(1-2):327-337. PubMed ID: 30393151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM; Fischer S; Csaba N; Kündig TM; Merkle HP; Gander B; Johansen P
    Pharm Res; 2007 Oct; 24(10):1927-35. PubMed ID: 17541735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 13. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
    McCluskie MJ; Weeratna RD; Davis HL
    Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles.
    Zhang XQ; Dahle CE; Weiner GJ; Salem AK
    J Pharm Sci; 2007 Dec; 96(12):3283-92. PubMed ID: 17497736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
    Hafner AM; Corthésy B; Textor M; Merkle HP
    Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.